132 related articles for article (PubMed ID: 1862552)
1. Experience with intrapleural natural beta interferon in the treatment of malignant pleural effusions.
Cascinu S; Isidori PP; Fedeli A; Fedeli SL; Raspugli M; Rossi A; Ugolini M; Catalano G
Tumori; 1991 Jun; 77(3):237-8. PubMed ID: 1862552
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural natural beta interferon in the treatment of malignant pleural effusions.
Rosso R; Rimoldi R; Salvati F; De Palma M; Cinquegrana A; Nicolò G; Ardizzoni A; Fusco U; Capaccio A; Centofanti R
Oncology; 1988; 45(3):253-6. PubMed ID: 2453008
[TBL] [Abstract][Full Text] [Related]
3. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
[TBL] [Abstract][Full Text] [Related]
4. Interferon instillation for malignant pleural effusions.
Goldman CA; Skinnider LF; Maksymiuk AW
Ann Oncol; 1993 Feb; 4(2):141-5. PubMed ID: 8448082
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
Sartori S; Tassinari D; Ceccotti P; Tombesi P; Nielsen I; Trevisani L; Abbasciano V
J Clin Oncol; 2004 Apr; 22(7):1228-33. PubMed ID: 15051770
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.
Sterman DH; Recio A; Haas AR; Vachani A; Katz SI; Gillespie CT; Cheng G; Sun J; Moon E; Pereira L; Wang X; Heitjan DF; Litzky L; June CH; Vonderheide RH; Carroll RG; Albelda SM
Mol Ther; 2010 Apr; 18(4):852-60. PubMed ID: 20068553
[TBL] [Abstract][Full Text] [Related]
7. Management of malignant pleural effusions.
Ruckdeschel JC
Semin Oncol; 1995 Apr; 22(2 Suppl 3):58-63. PubMed ID: 7740322
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interferon alpha-2b in the management of malignant pleural effusions.
Wilkins HE; Connolly MM; Grays P; Marquez G; Nelson D
Chest; 1997 Jun; 111(6):1597-9. PubMed ID: 9187180
[TBL] [Abstract][Full Text] [Related]
9. [Intrapleural administration of LAK cells combined with rIL2 in the treatment of advanced lung cancer with malignant pleural effusion].
Mao G; Gao Z; Wang Q
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):83-4, 127. PubMed ID: 7553956
[TBL] [Abstract][Full Text] [Related]
10. Management of malignant pleural effusion.
Taubert J
Nurs Clin North Am; 2001 Dec; 36(4):665-83, vi. PubMed ID: 11726346
[TBL] [Abstract][Full Text] [Related]
11. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
Kang MQ; Cao YP; Deng F
Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
[TBL] [Abstract][Full Text] [Related]
12. Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world.
Pan P; Wu F; Xu Z; Ji X; Qi Q; Huang X; Zhao R; Liu M; Jiang P; Li Y; Xu L
Thorac Cancer; 2021 Dec; 12(24):3416-3425. PubMed ID: 34741494
[TBL] [Abstract][Full Text] [Related]
13. The intrapleural administration of recombinant interleukin-2 (rIL-2) to patients with malignant pleural effusion: clinical trials.
Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K
Surg Today; 1993; 23(12):1053-9. PubMed ID: 8118118
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
Rusch VW; Figlin R; Godwin D; Piantadosi S
J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural Hyaluronidase in Viscous Malignant Mesothelioma Pleural Effusion.
Foo CT; Paterson A; Duckworth A; Herre J
Chest; 2021 Dec; 160(6):e609-e611. PubMed ID: 34872672
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion.
Matsuzaki Y; Shibata K; Yoshioka M; Inoue M; Sekiya R; Onitsuka T; Iwamoto I; Koga Y
Ann Thorac Surg; 1995 Jan; 59(1):127-31. PubMed ID: 7818311
[TBL] [Abstract][Full Text] [Related]
17. Malignant pleural effusions treated with high dose intrapleural doxycycline: clinical efficacy and tolerance.
Prevost A; Nazeyrollas P; Milosevic D; Fernandez-Valoni A
Oncol Rep; 1998; 5(2):363-6. PubMed ID: 9468558
[TBL] [Abstract][Full Text] [Related]
18. Malignant Pleural Effusion: From Diagnostics to Therapeutics.
Asciak R; Rahman NM
Clin Chest Med; 2018 Mar; 39(1):181-193. PubMed ID: 29433714
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.
Nie K; Zhang Z; You Y; Zhuang X; Zhang C; Ji Y
Thorac Cancer; 2020 Jan; 11(1):8-14. PubMed ID: 31726490
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions.
Foresti V
Respiration; 1995; 62(1):21-6. PubMed ID: 7716350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
